Biotech stocks are at a critical juncture, strategist says

On a technical level, the biotech charts concern Miller Tabak equity strategist Matt Maley.
Source: CNBC

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>